241 related articles for article (PubMed ID: 11433204)
1. Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients.
Andrzejewska-Buczko J; Pawlak D; Tankiewicz A; Matys T; Buczko W
Med Sci Monit; 2001; 7(4):742-5. PubMed ID: 11433204
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
Kanth VR; Lavanya K; Srinivas J; Raju TN
Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
[TBL] [Abstract][Full Text] [Related]
4. Diabetic cataract and the total antioxidant status in aqueous humor.
Aksoy H; Keles S; Koçer I; Akçay F
Clin Chem Lab Med; 2001 Feb; 39(2):143-5. PubMed ID: 11341748
[TBL] [Abstract][Full Text] [Related]
5. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
[TBL] [Abstract][Full Text] [Related]
6. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
Forrest CM; Mackay GM; Oxford L; Stoy N; Stone TW; Darlington LG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1078-87. PubMed ID: 17042918
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine and its metabolites in Alzheimer's disease patients.
Gulaj E; Pawlak K; Bien B; Pawlak D
Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
Bortolotti P; Hennart B; Thieffry C; Jausions G; Faure E; Grandjean T; Thepaut M; Dessein R; Allorge D; Guery BP; Faure K; Kipnis E; Toussaint B; Le Gouellec A
BMC Microbiol; 2016 Jul; 16(1):137. PubMed ID: 27392067
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
[TBL] [Abstract][Full Text] [Related]
11. [Parameters of oxidative stress in the lens, aqueous humor and blood in patients with diabetes and senile cataracts].
Zorić L
Srp Arh Celok Lek; 2003; 131(3-4):137-42. PubMed ID: 14608877
[TBL] [Abstract][Full Text] [Related]
12. Lenticular levels of amino acids and free UV filters differ significantly between normals and cataract patients.
Streete IM; Jamie JF; Truscott RJ
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4091-8. PubMed ID: 15505060
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of kynurenic acid in prefrontal cortex in a genetic animal model of depression.
Liu XC; Erhardt S; Goiny M; Engberg G; Mathé AA
Acta Neuropsychiatr; 2017 Feb; 29(1):54-58. PubMed ID: 27406788
[TBL] [Abstract][Full Text] [Related]
15. Gourami lenses convert tryptophan into 3-hydroxykynurenine.
Truscott RJ; Wood AM
Ophthalmic Res; 1994; 26(4):214-8. PubMed ID: 7808731
[TBL] [Abstract][Full Text] [Related]
16. The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound.
Chiarugi A; Rapizzi E; Moroni F; Moroni F
FEBS Lett; 1999 Jun; 453(1-2):197-200. PubMed ID: 10403402
[TBL] [Abstract][Full Text] [Related]
17. Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension.
Jasiewicz M; Moniuszko M; Pawlak D; Knapp M; Rusak M; Kazimierczyk R; Musial WJ; Dabrowska M; Kaminski KA
Heart; 2016 Feb; 102(3):230-7. PubMed ID: 26769378
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
19. Studies with tryptophan metabolites in vitro. Kynurenine metabolism in kidneys of mice infested with Schistosoma mansoni.
Amer MS; Abdel-Daim MH; Abdel-Tawab GA
Biochem J; 1968 Oct; 109(4):613-5. PubMed ID: 5683509
[TBL] [Abstract][Full Text] [Related]
20. Deamination of 3-hydroxykynurenine in bovine lenses: a possible mechanism of cataract formation in general.
Malina HZ; Martin XD
Graefes Arch Clin Exp Ophthalmol; 1995 Jan; 233(1):38-44. PubMed ID: 7721122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
